This is a Validated Antibody Database (VAD) review about cat CD9, based on 9 published articles (read how Labome selects the articles), using CD9 antibody in all methods. It is aimed to help Labome visitors find the most suited CD9 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Invitrogen
mouse monoclonal (MM2/57)
  • western blot; human; 1:1000; loading ...; fig 1c
Invitrogen CD9 antibody (Thermo Fisher, MM2/57) was used in western blot on human samples at 1:1000 (fig 1c). ERJ Open Res (2021) ncbi
mouse monoclonal (MM2/57)
  • flow cytometry; human; fig s1
In order to elucidate the role of CD151-alpha3beta1 integrin complexes in its cooperation with EGFR to drive tumor cell motility and invasion and as prognositic markers of glioblastoma, Invitrogen CD9 antibody (Biosource, MM2/57) was used in flow cytometry on human samples (fig s1). Oncotarget (2015) ncbi
mouse monoclonal (MM2/57)
  • western blot; mouse; fig 1
In order to identify agents that increase the levels of tetraspanins in macrophages, Invitrogen CD9 antibody (Biosource, clone MM2/57) was used in western blot on mouse samples (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (MM2/57)
  • flow cytometry; human; fig 6
  • western blot; human; fig 6
In order to investigate the role of CD9 in the cell adhesion-mediated drug resistance mechanism of small cell lung cancer, Invitrogen CD9 antibody (Biosource, MM2/57) was used in flow cytometry on human samples (fig 6) and in western blot on human samples (fig 6). Cancer Res (2010) ncbi
mouse monoclonal (MM2/57)
  • western blot; human; fig 2
In order to elucidate the contribution of DDR1 and type IV collagen to regulation of CD9-cell surface levels and migration of breast cancer cells, Invitrogen CD9 antibody (Biosource, MM2/57) was used in western blot on human samples (fig 2). Eur J Cell Biol (2010) ncbi
mouse monoclonal (MM2/57)
  • immunocytochemistry; human; fig 2
  • western blot; human; fig 5
In order to investigate the role of MT1-MMP-tetraspanin complexes in cancer cell invasion and metastasis, Invitrogen CD9 antibody (BioSource, MM2/57) was used in immunocytochemistry on human samples (fig 2) and in western blot on human samples (fig 5). Mol Biol Cell (2009) ncbi
mouse monoclonal (MM2/57)
  • western blot; human; fig 1
In order to examine the roles of CD9 and CD81 in cell motility and protease production of smoke-treated macrophages, Invitrogen CD9 antibody (BIOSOURCE, MM2/57) was used in western blot on human samples (fig 1). J Biol Chem (2008) ncbi
mouse monoclonal (MM2/57)
  • immunocytochemistry; human; fig 2
In order to determine the contribution of CD151 on breast cancer, Invitrogen CD9 antibody (Biosource, MM2/57) was used in immunocytochemistry on human samples (fig 2). Cancer Res (2008) ncbi
mouse monoclonal (MM2/57)
  • flow cytometry; human; fig 2A
  • immunoprecipitation; human; fig 2B
  • western blot; human; fig 2B
In order to investigate the role of CD9 in small cell lung cancer cells, Invitrogen CD9 antibody (Biosource, MM2/57) was used in flow cytometry on human samples (fig 2A), in immunoprecipitation on human samples (fig 2B) and in western blot on human samples (fig 2B). Cancer Res (2006) ncbi
Articles Reviewed
  1. Koba T, Takeda Y, Narumi R, Shiromizu T, Nojima Y, Ito M, et al. Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres. ERJ Open Res. 2021;7: pubmed publisher
  2. Zhou P, Erfani S, Liu Z, Jia C, Chen Y, Xu B, et al. CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion. Oncotarget. 2015;6:29675-93 pubmed publisher
  3. Jin Y, Tachibana I, Takeda Y, He P, Kang S, Suzuki M, et al. Statins decrease lung inflammation in mice by upregulating tetraspanin CD9 in macrophages. PLoS ONE. 2013;8:e73706 pubmed publisher
  4. Kohmo S, Kijima T, Otani Y, Mori M, Minami T, Takahashi R, et al. Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer. Cancer Res. 2010;70:8025-35 pubmed publisher
  5. Castro Sanchez L, Soto Guzman A, Navarro Tito N, Martinez Orozco R, Salazar E. Native type IV collagen induces cell migration through a CD9 and DDR1-dependent pathway in MDA-MB-231 breast cancer cells. Eur J Cell Biol. 2010;89:843-52 pubmed publisher
  6. Lafleur M, Xu D, Hemler M. Tetraspanin proteins regulate membrane type-1 matrix metalloproteinase-dependent pericellular proteolysis. Mol Biol Cell. 2009;20:2030-40 pubmed publisher
  7. Takeda Y, He P, Tachibana I, Zhou B, Miyado K, Kaneko H, et al. Double deficiency of tetraspanins CD9 and CD81 alters cell motility and protease production of macrophages and causes chronic obstructive pulmonary disease-like phenotype in mice. J Biol Chem. 2008;283:26089-97 pubmed publisher
  8. Yang X, Richardson A, Torres Arzayus M, Zhou P, Sharma C, Kazarov A, et al. CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization. Cancer Res. 2008;68:3204-13 pubmed publisher
  9. Saito Y, Tachibana I, Takeda Y, Yamane H, He P, Suzuki M, et al. Absence of CD9 enhances adhesion-dependent morphologic differentiation, survival, and matrix metalloproteinase-2 production in small cell lung cancer cells. Cancer Res. 2006;66:9557-65 pubmed